Cathie Wood, founder and CEO of ARK Investment Management, predicts President-elect Donald Trump‘s return to the White House will trigger significant economic growth through deregulation and tax cuts, ...

Ark Invest funds have been selling the electric vehicle maker's stock over the last few weeks and reinvesting the proceeds ...

Ark Invest CEO Cathie Wood delivered a glowing vision in a post-election message to investors, predicting President-elect ...

ARK Invest's Cathie Wood says that digital assets are ready for a historic run following the election of Donald Trump and an impending pro-crypto political climate.

If you're a growth investor, though, you should get to know Toast. It's an exciting, disruptive company with a quirky name ...

In a new Bloomberg podcast, Ark Invest CEO Cathie Wood explained her case for why Bitcoin beats gold as a 10-year safety investment. Bitcoin bull Cathie Wood believes gold's time has come and gone.

Cathie Wood Cashes Out On Rocket Lab's 28% Surge in $9M Share Sale But Expands Bet On Flying Cars Ross Gerber, Cathie Wood Or Gary Black? Whose Funds Stack Up Against S&P 500's Gains In 2024?

Cathie Wood of Ark Invest is best known for her high conviction in emerging themes, disrupting sectors such as technology or life sciences. While Wood has earned her share of media coverage ...

However, the stock does remain a holding of Cathie Wood's investment management firm ... colorectal cancer and precancerous lesions) was 90.6%, compared to Shield's 89.6%. Cologuard's better ...

The last quarter also saw a similar reduction at prices between $61.90 and $81.46. There was another ~20% selling this quarter at prices between $57.21 and $72.07. The stock currently trades at $ ...

Meanwhile, the next-gen Cologuard test's specificity for advanced neoplasia (including colorectal cancer and precancerous lesions) was 90.6%, compared to Shield's 89.6%. Cologuard's better ...